Polycystic Ovaries: A Cross Sectional Study on Unmarried Girls in KSA

Research Article

Austin J Obstet Gynecol. 2023; 10(1): 1211.

Polycystic Ovaries: A Cross Sectional Study on Unmarried Girls in KSA

*Corresponding author: Maha Al Qallaf Department of Computer Science and Engineering, Wright State University, USA

Received: November 17, 2022; Accepted: December 27, 2022; Published: January 02, 2023

Abstract

Polycystic ovaries often do not cause a disturbance in ovulation, and therefore it does not cause difficulties or problems in conceiving in most cases, but it also depends on the severity and size of the ovarian cysts. The causes of polycystic ovaries are not completely clear, but there are some factors that have a role in increasing the possibility of developing and developing this disorder, and these factors include obesity, family history, insulin resistance, inflammation in the body, which may increase insulin resistance. Polycystic ovary isn’t the same to Polycystic ovary syndrome.

The predominant endocrine disease that is rapidly spreading to epidemic levels is PCOS. For this syndrome, there are no community- based prevalence data available in KSA. In order to determine the prevalence of Polycystic Ovary Syndrome (PCOS) among 778 girls and adolescents aged 15–24 years, a community cross-sectional study was conducted in a census block taken from Mumbai. Six hundred of them completed all clinical, ultrasound, and biochemical tests. According to the Rotterdam criteria and 10.7% according to the Androgen Excess Association criteria, they had a prevalence of PCOS of 22.5%. 71.8% of PCOS cases according to the Rotterdam criteria were not infected with H. pylori. The most prevalent phenotype (52.6%) was mild PCOS (oligomenorrhea and polycystic ovary syndrome on USG).

Introduction

Polycystic Ovary (PCO) is one of the most common disorders among women and girls in adolescence and childbearing, also known as polycystic ovary. Ovarian cysts appear when detected using ultrasound in the form of a change in the nature of the growth of the follicles in which the eggs develop, which form part of the anatomical and functional structure of the ovary. Symptoms of PCOS in some girls include irregular menstruation or pain during ovulation, but it often does not cause pain in the pelvic area, but the possibility of pelvic pain increases with the presence of a cyst on the ovary or the development of ovarian cysts [1].

Polycystic Ovary Syndrome (PCOS) is a complex condition characterized by elevated androgen levels, menstrual irregularities, and/or small cysts on one or both ovaries. The disorder can be morphological (polycystic ovaries) or predominantly biochemical (hyperandrogenemia). Hyperandrogenism, a clinical hallmark of PCOS, can cause inhibition of follicular development, microcysts in the ovaries, anovulation, and menstrual changes. PCOS is a heterogeneous disorder that affects at least 7% of adult women. According to the National Institutes of Health Office of Disease Prevention, PCOS affects approximately 5 million women of childbearing age in the U.S. Costs to the U.S. health care system for the identification and management of PCOS are approximately $4 billion per year [2].

Normally, a group of follicles develops at the same time and spreads throughout the ovary, and these follicles are filled with fluid. In the case of ovarian cysts, the number of mature follicles increases at the same time and is larger and has a slightly different appearance. Ultrasound imaging, this is the primary examination to detect ovarian cysts. A physical exam, which may reveal some symptoms of PCOS, such as increased hair or acne. Laboratory blood tests, with the aim of detecting any hormonal imbalance, such as high androgen hormone, which often accompanies PCOS [3].

Objectives

This research aims to highlight on polycystic ovaries and the prevalence of the disease among unmarried women and those who do not have weight problems. And showing the differences between PCO and PCOS.

Research Question

1. What is PCO and PCOS?

2. Is the Polycystic ovary (PCO) same to Polycystic ovary syndrome (PCOS) ?

3. What are symptoms and causes of PCO? What is the diagnosis? What is the treatment?

4. The prevalence of the polycystic among unmarried women and those who do not have weight problems in KSA

Pathophysiology of PCOS

Primary abnormalities in the hypothalamic-pituitary axis, insulin secretion and action, and ovarian function are involved in the pathogenesis of PCOS. Obesity and insulin resistance have been linked to PCOS, despite the fact that the exact reason is uncertain. Since excess insulin causes the ovaries to produce androgens, which can cause anovulation, the association with insulin function is to be expected. Insulin regulates ovarian function. The hallmark of an ovarian anomaly is follicular maturation arrest [4].

Elevated levels of luteinizing hormone (LH) and gonadotropin- releasing hormone (GnRH), whereas muted or unaltered levels of follicular-stimulating hormone (FSH) are clinical indications of PCOS. The stimulation of the ovarian the cal cells as a result of the rise in GnRH results in an increase in androgen production. 10 FSH levels can be increased naturally or artificially to treat follicular arrest. According to several research, young girls who are nearing puberty and have a family history of PCOS are predisposed to the condition. Prolactin levels are high in about 25% of PCOS patients. The goal of therapeutic interventions is to lower insulin levels and ovarian androgen synthesis in order to balance sex hormone-binding globulin (SHBG) levels. The symptoms of PCOS can be efficiently managed by using this rise in SHBG levels. According to studies, PCOS patients’ thecal cells produce more testosterone, progesterone, and 17-hydroprogesterone than typical patients do [5].

Is the Polycystic Ovary (PCO) Same to Polycystic Ovary Syndrome (PCOS)

Understanding the distinction between having Polycystic Ovaries (PCO) and being diagnosed with a polycystic ovarian syndrome is a major source of misunderstanding for women (PCOS).

PCO is a term used to describe an ultrasound scan of what appear to be polycystic ovaries (ovaries containing high density of partially mature follicles).

A metabolic disorder called PCOS may or may not be accompanied by polycystic ovaries. In reality, two of the following must be present for a woman to be diagnosed with PCOS:

1) Ultrasound imaging shows polycystic ovaries.

2) Unusual cycles. 6

3) A blood test showing higher levels of male hormone or signs like additional hair growth or acne. Therefore, a woman may have PCOS without having polycystic ovaries if she experiences irregular periods and an increase in the male hormone. Before PCOS is diagnosed, though, other disorders including thyroid or pituitary abnormalities must be ruled out.

The hazards and medical treatments for these 2 situations are completely distinct, despite some name similarities. PCOS is a recognised disorder having both immediate and long-term effects, in contrast to PCO, which is a normal variation of a woman’s ovary. The key distinctions between the two will be outlined in this essay.

PCO is more common than PCOS: Up to one-third of women of reproductive age have polycystic ovaries on ultrasound but no other symptoms, making PCO more common. Contrarily, PCOS affects 12–18% of women of reproductive age, and 70% of these instances go untreated in the general population.

PCO is not a disease, whilst PCOS is a metabolic condition: While PCOS is a metabolic condition linked to improper hormone release from the female ovaries, PCO is a subtype of normal ovaries.

Women with PCOS are at risk of developing the associated short and long-term effects, whereas women with PCO are not: Women who have PCOS should be aware of the risk factors that may include endometrial cancer, diabetes, pregnancy difficulties (such as gestational diabetes), obesity, and cardiovascular disease. The risk profile for women with PCO varies.

PCOS has symptoms and is evident early in life whilst PCO has no symptoms and often discovered by chance: Both PCO and PCOS have a genetic component, however because to the related metabolic imbalance, PCOS frequently manifests symptoms (acne, excessive hair growth, etc.) throughout the teen years. PCO may also be present at a young age, but since there are no symptoms, it is only found by chance when the woman is older and having other health examinations.

Emergence of cysts in PCO may be caused by a variety of reasons as opposed to PCOS where is it linked to a hormonal disorder: Women with PCO may nonetheless have a balanced hormonal system and ovulate regularly. The hormonal balance is off in PCOS, which prevents ovulation from occurring. The mechanism in many of these women is related to excessive insulin release, which promotes androgen production from the ovary, interfering with ovulation.

Women with PCO can still get pregnant, whilst those with PCOS may struggle with infertility: While getting pregnant may not be problematic for PCO-positive women, it may be challenging for PCOS-positive women. Additionally, the chance of miscarriage is greater in women with PCOS.

Symptoms of PCO

Ovarian cysts may not cause any symptoms, and if some symptoms appear, they often start in the teenage or early twenties, and the nature of the symptoms of PCOS may vary between women .The severity of symptoms also varies according to the degrees of polycystic ovaries or if the cyst coincides with the presence of a cyst on the ovary, as there are mild cases of polycystic ovaries and there are severe 8 cases, and the symptoms of severe ovarian cysts may be similar to the symptoms of polycystic ovary syndrome [6].

Possible ovarian cyst symptoms include:

• overweight.

• Thinning and hair loss.

• Increased secretions of oily skin or acne.

• Excessive hair growth on the face, chest, back or buttocks, a condition called hirsutism.

• Difficulty getting pregnant or irregular ovulation [6].

Causes of PCO

The exact cause of PCOS isn’t known. Factors that might play a role include:

• Insulin sensitivity. A hormone produced by the pancreas is insulin. It permits the utilisation of sugar, the body’s main source of energy, by cells. Blood sugar levels may increase if cells develop an immunity to insulin’s effects. Your body may produce more insulin as a result in an effort to lower the blood sugar level.Too much insulin might cause your body to make too much of the male hormone androgen. You could have trouble with ovulation, the process where eggs are released from the ovary.

• Dark, velvety patches of skin in the groyne, armpits, or under the breasts are one indication of insulin resistance. Other symptoms could include a greater appetite and weight gain.

• Minimal inflammation In reaction to an infection or injury, white blood cells produce various chemicals. The reaction is referred to as low-grade Inflammation. According to research, patients with PCOS experience a specific kind of chronic, low-grade inflammation that causes their polycystic ovaries to manufacture androgens. Heart and blood vascular issues may result from this.

• Heredity. According to research, several genes may be connected to PCOS. A family history of PCOS may increase your risk of having the disease.

• More androgen. Ovarian androgen production may be elevated in people with PCOS. Ovulation is hampered by having too much androgen. This indicates that eggs do not consistently grow and are not released from the follicles where they do so. Hirsutism and acne can also be brought on by too much androgen.

The Prevalence of the Polycystic among Unmarried Women and Those Who Do Not Have Weight problems

PCOS prevalence varies greatly across the world, from 2.2% to as high as 26%. Women in the reproductive age range who participated in community-based research employing Rotterdam criteria showed varying prevalence rates in a few Asian nations, ranging from 2% to 7.5% in China to 6.3% in Sri Lanka. According to studies utilising NIH criteria, 5-8% of Caucasian populations had PCOS. According to Rotterdam criteria, an Australian retrospective birth cohort study of 728 women found a prevalence of 11.9 2.4%, which rose to 17.8 2.8% when imputed data were taken into account. PCOS prevalence was 10.2 2.2% according to AES recommendations and 12.0 2.4% using the imputed data. Observational research by endocrinologists, gynaecologists, and dermatologists relate to various elements of PCOS despite the fact that there are few studies of PCOS in KSA [7].

Due to urbanization and lifestyle changes, obesity and diabetes are becoming more common in most industrialized nations, including KSA. The majority of the young population waits for the problem to develop before visiting the health facility. The majority of prevalence studies conducted in KSA are conducted in hospitals, but some recent studies among school-aged adolescents reveal prevalence of PCOS from 9.13% to 36%. Gainie and Kalra point out that it is likely that KSA’s health budget will not be able to cover the cost of treating the many side effects associated with PCOS. It is imperative that this warning be taken seriously and that the disease be recognized as an important non-communicable disease on a national basis [8].

More widespread and liberal screening for the disorder appears to be a cost-effective strategy, benefiting from early diagnosis, intervention and possibly mitigating and preventing serious consequences. Studies have shown that the cost of a diagnostic evaluation makes up only about 2% of the total costs of managing PCOS. Therefore, the uneven prevalence of PCOS in general is primarily due to the use of different diagnostic criteria, heterogeneous presentation, and inconsistent treatment [9].

Methodology

In a randomly selected Mumbai census block, a community cross-sectional study was conducted between July 2010 and December 2011. It was decided that a sample size of 900 should be used, with a 95% confidence level and a prevalence of 10% and 2%, respectively. The total sample to be scored was calculated to be approximately 1000 cases, with a non-response rate of 10%. Girls aged 15-24 years who were unmarried, not yet pregnant, and who were willing to participate in the study were included. Based on the assumption that a block with a population of about 80,000 would have 19% of the female population in the 15–24 age group, an estimate of 10,600 eligible females was generated in the sample area. And 30% of them ineligible because they were married. Adolescents and young girls from every ten households were processed using a checklist of census data for households in the sampling area. All girls in the household who fulfilled the inclusion requirements were invited to participate in the study.

Participants

Young girls are between 20-24 years old.

Adolescents are 10-19 years (for our study 15-19 years).

Terminology

• Oligomenorrhea

An indirect indication of an ovulation in the absence of hormonal evidence, but considering that irregular menstrual cycles are spaced more than 35 days apart.

• Menopause

The absence of a period for a girl who has had menstruation for at least three of her previous cycles in total, or for a period of six months if she had amenorrhea.

• Polycystic ovaries

12 or more follicles with a diameter of 2 to 9 mm, with or without an ovary volume greater than 10 mm.

• BMI [19,20]

Underweight: BMI 17.9 kg/m2, overweight: BMI >23 kg/ m2, and obesity: BMI >25 kg/m2 for girls over 18. Age-matched body mass index (BMI) limits for girls under 18 years of age [19].

• The biochemistry of hyperandrogenism

Two standard deviations above the mean value among healthy controls for free androgen index (calculated using the formula: total testosterone/SHbg 100).

• Hyperandrogenism in adults

Freeman Galloway evaluated hirsutism. 8 out of 9 for body parts.

• Phenotypes

Phenotypes are classified from A to J (3) (Table 1) and then grouped together based on signs and symptoms including oligomenorrhea, polycystic ovaries (PCO appearance on ultrasound (USG), and clinical and biochemical hyperandrogenism). as PCOS, Frank, PCOS (phenotype J), PCOS (phenotypes B, D, and F) and Frank PCOS (phenotypes A, C, and E) (phenotypes G, H, and I).

Citation: Al Qallaf M. Polycystic Ovaries: A Cross Sectional Study on Unmarried Girls in KSA. Austin J Obstet Gynecol. 2023; 10(1): 1211.